Philip Serlin

Philip Serlin

Chief Executive Officer en BIOLINERX LTD. .

Fortuna: 13 138 $ al 31/03/2024

62 años
Consumer Services
Health Technology
Technology Services

Perfil

Philip Adam Serlin is currently the Chief Executive Officer at BioLineRx Ltd.
He previously served as an Independent Director at XWELL, Inc. from 2011 to 2012, an Independent Non-Executive Director at Vascular Biogenics Ltd., and an Independent Director at Purple Biotech Ltd.
from 2013 to 2016.
Additionally, he was the Chief Financial Officer at Tescom Software Systems Testing Ltd.
in 2007 and the Chief Operating & Financial Officer at Kayote Networks, Inc. in 2008.
He also held positions at Brightman Almagor Zohar & Co. and the US Securities & Exchange Commission.
Mr. Serlin holds a graduate degree from George Washington University and an undergraduate degree from Yeshiva University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/03/2024 171 900 ( 0.02% ) 13 138 $ 31/03/2024

Cargos activos de Philip Serlin

EmpresasCargoInicio
BIOLINERX LTD. Chief Executive Officer 10/10/2016
Todos los cargos activos de Philip Serlin

Antiguos cargos conocidos de Philip Serlin.

EmpresasCargoFin
PURPLE BIOTECH LTD Director/Board Member 01/01/2016
XWELL, INC. Director/Board Member 19/07/2012
Director of Finance/CFO 01/08/2008
Director of Finance/CFO 01/12/2007
US Securities & Exchange Commission Corporate Officer/Principal -
Ver el detalle de la experiencia de Philip Serlin.

Formación de Philip Serlin.

George Washington University Graduate Degree
Yeshiva University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Philip Serlin.

Relaciones

56

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
BIOLINERX LTD.

Health Technology

XWELL, INC.

Consumer Services

PURPLE BIOTECH LTD

Health Technology

Empresas privadas5

Technology Services

US Securities & Exchange Commission

Finance

Communications

Health Technology

Commercial Services

Ver las conexiones de la empresa